US Stock MarketDetailed Quotes

TG Therapeutics (TGTX)

Watchlist
  • 34.300
  • -0.300-0.87%
Close Apr 16 16:00 ET
  • 34.355
  • +0.055+0.16%
Post 18:14 ET
5.48BMarket Cap12.38P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

TG Therapeutics (TGTX) Revenue Breakdown Overview

By Business/Source

Currency:USD
2025/FY
Stock NameRevenueRatio
BRIUMVI606.93M98.48%
License, milestone, royalty and other revenue9.36M1.52%

By Country/Region

Currency:USD
2025/FY
Stock NameRevenueRatio
United States594.11M96.40%
International12.82M2.08%
Royalty revenue5.62M0.91%
Other revenue3.59M0.58%
License revenue152K0.02%
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +6.33%
Sample Name
Sample Code
 +4.40%
Sample Name
Sample Code
 +3.43%
4
United States Gasoline Fund Lp
UGA
+0.46%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
-1.17%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.08%
Sample Name
Sample Code
 +16.18%
Sample Name
Sample Code
 +15.82%
4
Baidu
BIDU
+15.52%
5
Zai Lab
ZLAB
+13.31%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Trump stated on the 15th that the US-Iran war is 'about to end,' with an agreement expected to be reached before the end of April. However, Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -